Becton Dickinson & Co
BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3017% above fair value
$215.42−1.05 (-0.49%)
Close on Nov 17, 2026Market cap $58.68BP/E 65.1Yield 1.93%
Becton Dickinson Developed Markets — Reported Revenue Growth YoY by Quarter
Developed Markets — Reported Revenue Growth YoY (%) (%)
Becton Dickinson Developed Markets — Reported Revenue Growth YoY: 4.8% in Q4 FY26.
Latest, Q4 FY26
4.8%
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
–
History
6 quarters
Since Q4 FY23
Sources
6
Documents cited below
Where the Q4 FY26 figure comes from
“DEVELOPED MARKETS REVENUES $ 4,575 $ 4,366 $ (25) 4.8 5.4”
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Developed Markets — Reported Revenue Growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q4 FY26CQ3 2026 | Sep 30, 2026 | 4.8% | – | BD Q4 FY2026 Earnings Presentation ↗ |
| Q3 FY26CQ2 2026 | Jun 30, 2026 | 6.1% | – | BD Q3 FY2026 Earnings Presentation ↗ |
| Q2 FY26CQ1 2026 | Mar 31, 2026 | 4.8% | – | BD Q2 FY2026 Earnings Presentation ↗ |
| Q1 FY26CQ4 2025 | Dec 31, 2025 | 2.2% | – | BD Q1 FY2026 Earnings Presentation ↗ |
| Q1 FY24CQ4 2023 | Dec 31, 2023 | 2.7% | – | BD Q1 FY2024 Earnings Presentation ↗ |
| Q4 FY23CQ3 2023 | Sep 30, 2023 | 8.6% | – | BD Q4 FY2023 Earnings Presentation ↗ |
Cite this data
StockData. (2026). Becton Dickinson Developed Markets — Reported Revenue Growth YoY (%), quarterly Q4 FY23–Q4 FY26 [Data set]. Compiled from Becton Dickinson SEC filings and investor materials. https://stockdatahq.com/stocks/bdx/kpis/geo-dev-rep
See every metric in the Becton Dickinson KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?